Joshua Reed
2023 - Omega Therapeutics
In 2023, Joshua Reed earned a total compensation of $907K as Chief Financial Officer at Omega Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $182,988 |
|---|---|
| Option Awards | $247,610 |
| Salary | $465,000 |
| Other | $11,400 |
| Total | $906,998 |
Reed received $465K in salary, accounting for 51% of the total pay in 2023.
Reed also received $183K in non-equity incentive plan, $247.6K in option awards and $11.4K in other compensation.
Rankings
In 2023, Joshua Reed's compensation ranked 1,323rd out of 3,006 executives tracked by ExecPay. In other words, Reed earned more than 56.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,323 out of 3,006 | 56th |
Division Manufacturing | 793 out of 1,650 | 52nd |
Major group Chemicals And Allied Products | 526 out of 918 | 43rd |
Industry group Drugs | 513 out of 881 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 146 out of 213 | 32nd |
Source: SEC filing on April 29, 2024.
Reed's colleagues
We found two more compensation records of executives who worked with Joshua Reed at Omega Therapeutics in 2023.